Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Inventory (2023 - 2025)

Bioregenx's Inventory history spans 3 years, with the latest figure at $106931.0 for Q4 2025.

  • Quarterly results put Inventory at $106931.0 for Q4 2025, down 3.75% from a year ago — trailing twelve months through Dec 2025 was $106931.0 (down 3.75% YoY), and the annual figure for FY2025 was $106931.0, down 3.75%.
  • Inventory for Q4 2025 was $106931.0 at Bioregenx, down from $109378.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $217529.0 in Q4 2023 to a low of $106931.0 in Q4 2025.
  • The 3-year median for Inventory is $140438.0 (2025), against an average of $148399.0.
  • The sharpest move saw Inventory crashed 48.93% in 2024, then fell 3.75% in 2025.
  • Year by year, Inventory stood at $217529.0 in 2023, then crashed by 48.93% to $111094.0 in 2024, then dropped by 3.75% to $106931.0 in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $106931.0, $109378.0, and $134228.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.